Fenton Benjamin B

Show results for

Unknown (10)
Proteomics (2)

Organisms

Megalopygidae sp. BOLD:AAA3544 (2)
Burkholderia sp. H5.7(2011) (2)
Polaribacter sp. Q13 (2)
Pseudomonas syringae pv. tomato (2)
Tenacibaculum dicentrarchi (2)
Ornithodoros sp. AJM-2011b (2)
Papio anubis anubis (2)
Capra (2)
Lutjanidae (2)
Serranidae (2)
Labridae (2)
Penaeus (2)
Phasianidae sp. (2)
Chloroflexota (2)
Human alphaherpesvirus 3 (2)
Mesotaenium endlicherianum (2)
Robinia pseudoacacia (2)
Zygnema circumcarinatum (2)
Nostoc punctiforme PCC 73102 (2)
Photorhabdus luminescens (2)
Picosynechococcus sp. PCC 11901 (2)
Thermaerobacillus caldiproteolyticus (2)
Phikzvirus phiKZ (2)
Zymomonas mobilis (2)
Mycobacterium tuberculosis GM 1503 (2)
Desulfobacteraceae bacterium (2)
Methanosarcinales archaeon (2)
Taenia hydatigena (2)
Francisella tularensis subsp. novicida (2)
Streptomyces sp. PU10 (2)

Repository

pride (2)

Tissue

Blood serum (1)
Cell culture (1)

Technology Type

Mass Spectrometry (2)
Shotgun proteomics (2)
SWATH MS (1)

Publication Date

2023 (1)
2020 (1)

Release Date

2022 (2)
2021 (2)
2011 (2)
2024 (1)
2019 (1)
2018 (1)
2013 (1)

Lab affiliation

National Institute of Standards and Technology (1)
Director, Robert H. Lurie Comprehensive Cancer Center Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Surveying the vampire bat (Desmodus rotundus) serum proteome: a resource for identifying immunological proteins and detecting pathogens

Bats are increasingly studied as model systems for longevity and as natural hosts to some virulent viruses. Yet our ability to characterize immune mechanisms of viral tolerance and to quantify infection dynamics in wild bats is often limited by small sample volumes and few species-specific reagents....

ORGANISM(S): Desmodus rotundus

2020-12-07 | PXD022885 | Pride

ULK1 as a novel therapeutic target to enhance immune checkpoint therapies against melanoma

Immune checkpoint inhibitors (ICIs) have transformed the treatment of melanoma. However, the majority of patients have primary or acquired resistance to ICIs, limiting durable responses and patient survival. Interferon-gamma (IFNg) signaling and the expression of IFNg-stimulated genes correlate with...

ORGANISM(S): Homo sapiens (Human)

2023-02-02 | PXD035347 | Pride

Irf1 Interferon-gamma Ulk1 Melanoma Pd-l1 Signaling Immune checkpoint inhibitors

Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

Not available

S-EPMC8796794 | biostudies-literature

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.

Not available

S-EPMC6105323 | biostudies-literature

Results of the two incidence screenings in the National Lung Screening Trial.

Not available

S-EPMC4307922 | biostudies-literature